Clinical trial
Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving…
NCT00137579 · Catalan Institute of Health, Other · Completed
Key facts
| NCT number | NCT00137579 |
|---|---|
| Title | Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy |
| Official title | Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation |
| Lead sponsor | Catalan Institute of Health, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Procedure |
| Interventions | Influenza vaccine intramuscular administration route |
| Enrollment | 216 |
| Start date | Sep 1, 2003 |
| Completion | May 1, 2004 |
| First posted | Aug 30, 2005 |
| Last update posted | Dec 13, 2005 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: